Effects of growth hormone administration for 6 months on bone turnover and bone marrow fat in obese premenopausal women.

[1]  J. González‐Macías,et al.  Bone mineral density in statin users: a population-based analysis from a Spanish cohort , 2014, Journal of Bone and Mineral Metabolism.

[2]  Binsheng Zhao,et al.  Abdominal fat is associated with lower bone formation and inferior bone quality in healthy premenopausal women: a transiliac bone biopsy study. , 2013, The Journal of clinical endocrinology and metabolism.

[3]  D. Schoenfeld,et al.  Effects of GH in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trial. , 2012, European journal of endocrinology.

[4]  Julie Flahive,et al.  Obesity is not protective against fracture in postmenopausal women: GLOW. , 2011, The American journal of medicine.

[5]  N. Weissman,et al.  A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial. , 2011, The Journal of clinical endocrinology and metabolism.

[6]  M. Bredella,et al.  Adiponectin Is Inversely Associated With Intramyocellular and Intrahepatic Lipids in Obese Premenopausal Women , 2011, Obesity.

[7]  A. Breggia,et al.  Determinants of bone mineral density in obese premenopausal women. , 2011, Bone.

[8]  M. Bredella,et al.  Vertebral Bone Marrow Fat Is Positively Associated With Visceral Fat and Inversely Associated With IGF‐1 in Obese Women , 2011, Obesity.

[9]  Martin Torriani,et al.  Comparison of DXA and CT in the Assessment of Body Composition in Premenopausal Women With Obesity and Anorexia Nervosa , 2010, Obesity.

[10]  Arya M. Sharma,et al.  Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. , 2010, The New England journal of medicine.

[11]  M. Bredella,et al.  Comparison of 3.0 T proton magnetic resonance spectroscopy short and long echo‐time measures of intramyocellular lipids in obese and normal‐weight women , 2010, Journal of magnetic resonance imaging : JMRI.

[12]  R. DePinho,et al.  Insulin Signaling in Osteoblasts Integrates Bone Remodeling and Energy Metabolism , 2010, Cell.

[13]  Chao Wan,et al.  Insulin Receptor Signaling in Osteoblasts Regulates Postnatal Bone Acquisition and Body Composition , 2010, Cell.

[14]  D. Sahani,et al.  Breath-Hold 1H-Magnetic Resonance Spectroscopy for Intrahepatic Lipid Quantification at 3 Tesla , 2010, Journal of computer assisted tomography.

[15]  S. Yakar,et al.  Growth Hormone Regulates the Balance Between Bone Formation and Bone Marrow Adiposity , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  M. Bredella,et al.  Peak growth hormone-releasing hormone-arginine-stimulated growth hormone is inversely associated with intramyocellular and intrahepatic lipid content in premenopausal women with obesity. , 2009, The Journal of clinical endocrinology and metabolism.

[17]  S. Mittelman,et al.  Reciprocal relations of subcutaneous and visceral fat to bone structure and strength. , 2009, The Journal of clinical endocrinology and metabolism.

[18]  M. Bredella,et al.  Increased bone marrow fat in anorexia nervosa. , 2009, The Journal of clinical endocrinology and metabolism.

[19]  D. Schoenfeld,et al.  Anthropometry, CT, and DXA as predictors of GH deficiency in premenopausal women: ROC curve analysis. , 2009, Journal of applied physiology.

[20]  C. Ackert-Bicknell,et al.  Marrow fat and the bone microenvironment: developmental, functional, and pathological implications. , 2009, Critical reviews in eukaryotic gene expression.

[21]  G. Mazziotti,et al.  Growth hormone, insulin-like growth factors, and the skeleton. , 2008, Endocrine reviews.

[22]  Kunihiro Matsumoto,et al.  Suppression of PPAR Transactivation Switches Cell Fate of Bone Marrow Stem Cells from Adipocytes into Osteoblasts , 2007, Annals of the New York Academy of Sciences.

[23]  M. McKee,et al.  Endocrine Regulation of Energy Metabolism by the Skeleton , 2007, Cell.

[24]  S. Cummings,et al.  Inflammatory Markers and Incident Fracture Risk in Older Men and Women: The Health Aging and Body Composition Study , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  T. Jensen,et al.  Dlk1/FA1 is a novel endocrine regulator of bone and fat mass and its serum level is modulated by growth hormone. , 2007, Endocrinology.

[26]  J. Bollerslev,et al.  Positive effects of a physiological dose of GH on markers of atherogenesis: a placebo-controlled study in patients with adult-onset GH deficiency. , 2006, European journal of endocrinology.

[27]  M. Visser,et al.  Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. , 2005, The Journal of clinical endocrinology and metabolism.

[28]  Y. Khang,et al.  Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis , 2005, Osteoporosis International.

[29]  J. Aloia,et al.  Influence of growth hormone on bone marrow adipogenesis in hypophysectomized rats. , 2003, American journal of physiology. Endocrinology and metabolism.

[30]  K. Rácz,et al.  Effects of 24 Months of Growth Hormone (GH) Treatment on Serum Carboxylated and Undercarboxylated Osteocalcin Levels in GH-Deficient Adults , 2003, Calcified Tissue International.

[31]  I. Robinson,et al.  Bone marrow adipocytes: a neglected target tissue for growth hormone. , 2002, Endocrinology.

[32]  C. Hagen,et al.  Fetal antigen 1 in healthy adults and patients with pituitary disease: relation to physiological, pathological, and pharmacological GH levels. , 2001, The Journal of clinical endocrinology and metabolism.

[33]  H. Pijl,et al.  Altered neuroregulation of GH secretion in viscerally obese premenopausal women. , 2001, The Journal of clinical endocrinology and metabolism.

[34]  C. Edwards,et al.  Oral statins and increased bone-mineral density in postmenopausal women , 2000, The Lancet.

[35]  S. Adami,et al.  Chronic Intravenous Aminobisphosphonate Therapy Increases High‐Density Lipoprotein Cholesterol and Decreases Low‐Density Lipoprotein Cholesterol , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[36]  F. Parhami,et al.  Atherogenic Diet and Minimally Oxidized Low Density Lipoprotein Inhibit Osteogenic and Promote Adipogenic Differentiation of Marrow Stromal Cells , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[37]  J. Jørgensen,et al.  Determinants of serum insulin‐like growth factor I in growth hormone deficient adults as compared to healthy subjects , 1998, Clinical endocrinology.

[38]  F. Parhami,et al.  Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[39]  S. Wei,et al.  Growth hormone increases serum 1,25-dihydroxyvitamin D levels and decreases 24,25-dihydroxyvitamin D levels in children with growth hormone deficiency. , 1997, European journal of endocrinology.

[40]  D. Schoenfeld,et al.  Effects of Physiologic Growth Hormone Therapy on Bone Density and Body Composition in Patients with Adult-Onset Growth Hormone Deficiency , 1996, Annals of Internal Medicine.

[41]  L. Mosekilde,et al.  Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study. , 1996, The Journal of clinical endocrinology and metabolism.

[42]  C. Morrison,et al.  Waist circumference as a measure for indicating need for weight management , 1995, BMJ.